Biotech and pharma diversification pays off
![Biotech and pharma diversification pays off](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/d23c3f95c1a4b87759dfb2acec18b423.jpg)
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
https://seekingalpha.com/author/alexander-carchidi?source=ie_podcast:biotech_pharma_diversification_pays_off dissects the biotech sector - mostly highly risky, borderline investments. Diversification pays off (3:40). Funding is hard to come by and performance has not been great but ebb will...
show moreShow Notes:
CRISPR/Vertex gene editing therapy approved in U.S. for beta-thalassemia
First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets.
Lilly, Novo Nordisk diabetes drugs see price raises - report
Episode transcripts
For full access to analyst ratings, stock quant scores as well as dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Comments
![Brandon Clifford](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_100/images.spreaker.com/original/8bf4e97814c1eb1150c0b7daff5cadc2.jpg)
Brandon Clifford
6 months ago
Information
Author | Seeking Alpha |
Organization | Seeking Alpha |
Website | seekingalpha.com |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company